tiprankstipranks

iKena Oncology reports Q3 EPS (21c), consensus (27c)

As of September 30, 2024, the Company had cash, cash equivalents, and marketable securities of $138.0 million.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

1